These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17005381)

  • 21. Preclinical studies for gene therapy of Duchenne muscular dystrophy.
    Odom GL; Banks GB; Schultz BR; Gregorevic P; Chamberlain JS
    J Child Neurol; 2010 Sep; 25(9):1149-57. PubMed ID: 20498332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress in gene therapy for Duchenne muscular dystrophy.
    Clemens PR; Duncan FJ
    Curr Neurol Neurosci Rep; 2001 Jan; 1(1):89-96. PubMed ID: 11898504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy for muscle disease.
    Miyagoe-Suzuki Y; Takeda S
    Exp Cell Res; 2010 Nov; 316(18):3087-92. PubMed ID: 20580709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skipping multiple exons of dystrophin transcripts using cocktail antisense oligonucleotides.
    Echigoya Y; Yokota T
    Nucleic Acid Ther; 2014 Feb; 24(1):57-68. PubMed ID: 24380394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The search for a cure for Duchenne muscular dystrophy (DMD).
    Acta Myol; 2005 Dec; 24(3):169-71. PubMed ID: 16629049
    [No Abstract]   [Full Text] [Related]  

  • 26. Gene therapy progress and prospects: Duchenne muscular dystrophy.
    Foster K; Foster H; Dickson JG
    Gene Ther; 2006 Dec; 13(24):1677-85. PubMed ID: 17066097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impending therapies for Duchenne muscular dystrophy.
    Partridge TA
    Curr Opin Neurol; 2011 Oct; 24(5):415-22. PubMed ID: 21892079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-viral approaches for gene transfer.
    Wolff J; Lewis DL; Herweijer H; Hegge J; Hagstrom J
    Acta Myol; 2005 Dec; 24(3):202-8. PubMed ID: 16629054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of therapy for Duchenne muscular dystrophy.
    Zhang S; Xie H; Zhou G; Yang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):194-203. PubMed ID: 17357471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy for Duchenne muscular dystrophy: AAV leads the way.
    Judge LM; Chamberlain JS
    Acta Myol; 2005 Dec; 24(3):184-93. PubMed ID: 16629052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular therapeutic strategies targeting Duchenne muscular dystrophy.
    Mendell JR; Rodino-Klapac LR; Malik V
    J Child Neurol; 2010 Sep; 25(9):1145-8. PubMed ID: 20498331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Less is more: therapeutic exon skipping for Duchenne muscular dystrophy.
    Aartsma-Rus A; van Ommen GJ
    Lancet Neurol; 2009 Oct; 8(10):873-5. PubMed ID: 19713153
    [No Abstract]   [Full Text] [Related]  

  • 33. Cell based therapy for Duchenne muscular dystrophy.
    Farini A; Razini P; Erratico S; Torrente Y; Meregalli M
    J Cell Physiol; 2009 Dec; 221(3):526-34. PubMed ID: 19688776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy.
    Takeshima Y; Yagi M; Wada H; Ishibashi K; Nishiyama A; Kakumoto M; Sakaeda T; Saura R; Okumura K; Matsuo M
    Pediatr Res; 2006 May; 59(5):690-4. PubMed ID: 16627883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nonsense readthrough therapy for Duchenne muscular dystrophy].
    Takeshima Y
    Rinsho Shinkeigaku; 2014; 54(12):1074-6. PubMed ID: 25672712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy for duchenne muscular dystrophy: expectations and challenges.
    Rodino-Klapac LR; Chicoine LG; Kaspar BK; Mendell JR
    Arch Neurol; 2007 Sep; 64(9):1236-41. PubMed ID: 17846262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting mRNA splicing as a potential treatment for Duchenne muscular dystrophy.
    Kole R; Leppert BJ
    Discov Med; 2012 Jul; 14(74):59-69. PubMed ID: 22846203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exon-skipping events in candidates for clinical trials of morpholino.
    Nakano S; Ozasa S; Yoshioka K; Fujii I; Mitsui K; Nomura K; Kosuge H; Endo F; Matsukura M; Kimura S
    Pediatr Int; 2011 Aug; 53(4):524-9. PubMed ID: 21342350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense oligonucleotides, exon skipping and the dystrophin gene transcript.
    Wilton SD; Fletcher S
    Acta Myol; 2005 Dec; 24(3):222-9. PubMed ID: 16629057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utrophin upregulation in Duchenne muscular dystrophy.
    Hirst RC; McCullagh KJ; Davies KE
    Acta Myol; 2005 Dec; 24(3):209-16. PubMed ID: 16629055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.